This is a public record generated listing.
Assets of Clinical Stage Neuro-Biotechnology Company
Listing Information
Attachments
Assets of Clinical Stage Neuro-Biotechnology Company
Price: Not Specified
Other Item Info
Item #: debke_192048
Created: 03/23/2024
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: Belmar, New Jersey
Sale Date: Wed. May 1, 2024
Created: 03/23/2024
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: Belmar, New Jersey
Sale Date: Wed. May 1, 2024
Seller Info
Michael G. Busenkell
Debtor's Attorney
913 N. Market St. 10th Floor
Wilmington, DE 19801
302-425-5812
Debtor's Attorney
913 N. Market St. 10th Floor
Wilmington, DE 19801
302-425-5812
Bankruptcy Info
Case #: 1:24-bk-10153
Case Title: DMK Pharmaceuticals Corporation
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Case Title: DMK Pharmaceuticals Corporation
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Description
Auction Sale of substantially all of assets of DMK Pharmaceuticals Corporation (“DMK”), and its affiliated sellers (collectively, the “Sellers”), including but not limited to the equipment, intellectual property, unexpired leases, contract rights, and other assets related to or necessary to operate the business currently operated by the sellers.
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume:
Additional Details
- Auction Time: 10:00 a.m.
- Sale Hearing Held on May 6, 2024.
- Bid Increment: $100,000
- Bid Deposit: 10% of the cash consideration of the Bid
- Bid Deadline: April 26, 2024
- Last date to respond: May 3, 2024